NCT00274131View on ClinicalTrials.gov

Long-term Administration Study of SND 919 Tablets in Parkinson's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

December 31, 1998

Study Completion Date

February 29, 2004

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole 0.125 mg tablets

DRUG

Pramipexole 0.5 mg tablets

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY